363 related articles for article (PubMed ID: 28222635)
1. Serum betatrophin levels are increased and associated with insulin resistance in patients with polycystic ovary syndrome.
Qu Q; Zhao D; Zhang F; Bao H; Yang Q
J Int Med Res; 2017 Feb; 45(1):193-202. PubMed ID: 28222635
[TBL] [Abstract][Full Text] [Related]
2. Elevated circulating levels of betatrophin are associated with polycystic ovary syndrome.
Calan M; Yilmaz O; Kume T; Unal Kocabas G; Yesil Senses P; Senses YM; Temur M; Gursoy Calan O
Endocrine; 2016 Jul; 53(1):271-9. PubMed ID: 26832343
[TBL] [Abstract][Full Text] [Related]
3. [Elevated serum levels of betatrophin in patients with polycystic ovary syndrome and the influential factors].
Song S; Wang J; Guo C; Jiang T
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Sep; 41(9):969-74. PubMed ID: 27640796
[TBL] [Abstract][Full Text] [Related]
4. Association of betatrophin with metabolic characteristics in overweight/obese and lean women with PCOS.
Li L; Zhang F; Cui J; Shi Y; Xiang J; Wang X; Zhao N; Yan Q; Greenberg AS; Peng Y; Ding X
Gynecol Endocrinol; 2017 Mar; 33(3):238-243. PubMed ID: 27960599
[TBL] [Abstract][Full Text] [Related]
5. Assessment of circulating betatrophin concentrations in lean glucose-tolerant women with polycystic ovary syndrome.
Erol O; Özel MK; Ellidağ HY; Toptaş T; Derbent AU; Yılmaz N
J Obstet Gynaecol; 2017 Jul; 37(5):633-638. PubMed ID: 28319674
[TBL] [Abstract][Full Text] [Related]
6. Serum betatrophin levels are reduced in patients with full-blown polycystic ovary syndrome.
Eksi Haydardedeoglu F; Bagir GS; Haydardedeoglu B; Bozkirli E; Bakiner O; Metin K; Ertorer ME
Gynecol Endocrinol; 2019 Mar; 35(3):224-227. PubMed ID: 30241452
[TBL] [Abstract][Full Text] [Related]
7. Association of serum betatrophin with fibroblast growth factor-21 in women with polycystic ovary syndrome.
Kahraman S; Altinova AE; Yalcin MM; Gulbahar O; Arslan B; Akturk M; Cakir N; Toruner FB
J Endocrinol Invest; 2018 Sep; 41(9):1069-1074. PubMed ID: 29363048
[TBL] [Abstract][Full Text] [Related]
8. Adipose Insulin Resistance and Circulating Betatrophin Levels in Women with PCOS.
He Y; Hu W; Yang G; Guo H; Liu H; Li L
Biomed Res Int; 2020; 2020():1253164. PubMed ID: 32076603
[TBL] [Abstract][Full Text] [Related]
9. The correlation of plasma omentin-1 with insulin resistance in non-obese polycystic ovary syndrome.
Yang HY; Ma Y; Lu XH; Liang XH; Suo YJ; Huang ZX; Lu DC; Qin YF; Luo ZJ
Ann Endocrinol (Paris); 2015 Oct; 76(5):620-7. PubMed ID: 26514948
[TBL] [Abstract][Full Text] [Related]
10. Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome.
Yildiz BO; Yarali H; Oguz H; Bayraktar M
J Clin Endocrinol Metab; 2003 May; 88(5):2031-6. PubMed ID: 12727950
[TBL] [Abstract][Full Text] [Related]
11. Relationship between betatrophin levels and metabolic parameters in patients with polycystic ovary syndrome.
Erbag G; Eroglu M; Turkon H; Sen H; Binnetoglu E; Aylanc N; Asik M
Cell Mol Biol (Noisy-le-grand); 2016 Apr; 62(5):20-4. PubMed ID: 27188865
[TBL] [Abstract][Full Text] [Related]
12. Circulating Angiopoietin-like 8 protein (ANGPTL8/Betatrophin) in patients with polycystic ovary syndrome: a systematic review and multi effect size meta-analysis.
Varikasuvu SR; Panga JR; Satyanarayana MV
Gynecol Endocrinol; 2019 Mar; 35(3):190-197. PubMed ID: 30614305
[TBL] [Abstract][Full Text] [Related]
13. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
[TBL] [Abstract][Full Text] [Related]
14. [Obesity, hormonal and metabolic abnormalities in adolescent girls with polycystic ovary syndrome].
Ságodi L; Lombay B; Vámosi I; Barkai L
Orv Hetil; 2013 Aug; 154(31):1226-34. PubMed ID: 23895991
[TBL] [Abstract][Full Text] [Related]
15. Elevated serum levels of interleukin-18 are associated with insulin resistance in women with polycystic ovary syndrome.
Zhang YF; Yang YS; Hong J; Gu WQ; Shen CF; Xu M; Du PF; Li XY; Ning G
Endocrine; 2006 Jun; 29(3):419-23. PubMed ID: 16943580
[TBL] [Abstract][Full Text] [Related]
16. Serum total L-carnitine levels in non-obese women with polycystic ovary syndrome.
Fenkci SM; Fenkci V; Oztekin O; Rota S; Karagenc N
Hum Reprod; 2008 Jul; 23(7):1602-6. PubMed ID: 18378560
[TBL] [Abstract][Full Text] [Related]
17. Circulating ghrelin levels in patients with polycystic ovary syndrome.
Schöfl C; Horn R; Schill T; Schlösser HW; Müller MJ; Brabant G
J Clin Endocrinol Metab; 2002 Oct; 87(10):4607-10. PubMed ID: 12364442
[TBL] [Abstract][Full Text] [Related]
18. Plasma adiponectin levels in women with polycystic ovary syndrome: impact of metformin treatment in a case-control study.
Singh S; Akhtar N; Ahmad J
Diabetes Metab Syndr; 2012; 6(4):207-11. PubMed ID: 23199540
[TBL] [Abstract][Full Text] [Related]
19. Adiponectin levels in women with polycystic ovary syndrome and severe insulin resistance.
Sepilian V; Nagamani M
J Soc Gynecol Investig; 2005 Feb; 12(2):129-34. PubMed ID: 15695109
[TBL] [Abstract][Full Text] [Related]
20. Insulin resistance in nonobese patients with polycystic ovary syndrome.
Toprak S; Yönem A; Cakir B; Güler S; Azal O; Ozata M; Corakçi A
Horm Res; 2001; 55(2):65-70. PubMed ID: 11509861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
